Jul 15,2022

Akili’s digital therapeutic tech improves cognitive function in lupus patients: study

A recently published study found that Akili’s AKL-T01 program—which was cleared by the FDA in 2020 under the product name EndeavorRx to improve attention function in children with attention-deficit/hyperactivity disorder (ADHD)—can also be successfully used by adults with systemic lupus erythematosus to boost cognitive function.

CLINICAL STUDY

#cbt

View Analyst & Ambassador Comments
Go to original news
Jul 25,2022

First-of-its-kind partnership provides free access to digital mental health treatments for all newly diagnosed cancer patients in the United Kingdom

Newly diagnosed cancer patients across the United Kingdom (UK) are now able to easily access innovative and effective treatments to support their mental health thanks to a new partnership between Macmillan Cancer Support and digital therapeutics company Big Health, makers of Sleepio and Daylight. The partnership between Macmillan and Big Health will provide newly diagnosed cancer patients aged 18 and older residing in England, Wales, and Northern Ireland free access to Sleepio for insomnia and Daylight for anxiety to manage their mental health needs.

COLLABORATION PARTNERSHIP

#institution

#cbt

View Analyst & Ambassador Comments
Go to original news
Aug 09,2022

Limbix launches the Limbix Synapse platform to enable the development of robust and secure digital therapeutics

Today Limbix Health, Inc. (Limbix), the leader in developing evidence-based, digital therapeutics for adolescent mental health, announced the launch of its Limbix Synapse platform. Through the platform, Limbix is able to efficiently build, distribute, and commercialize secure, compliant, and privacy-aware digital therapeutics. Developed on the Limbix Synapse platform, SparkRx™ is now available for licensed health care professionals to offer as adjunct treatment to adolescent patients with symptoms of depression in the US. With the Limbix Synapse platform, Limbix is able to quickly build, test, and monitor clinical-grade therapeutics through the platform's mobile therapeutic development system, ensuring their security and compliance.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 11,2022

DarioHealth Selected by National Health Plan to Enhance Mental Health and Well-Being for Members

DarioHealth Corp. ("Dario", "DarioHealth" or the "Company") (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that a national health plan (the "Plan"), selected Dario's behavioral health solution to drive self-service across its mental wellbeing care resources. Dario's solution will become part of the Plan's behavioral health platform to increase access to digital navigation, digital self-help and coaching.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Aug 14,2022

Memorandum of Understanding (MoU) signed between Macquarie University and TALi (Health) Digital

Tali Health announce that a five year Memorandum of Understanding (MoU) has been signed between Macquarie University and TALi (Health) Digital. Both parties have entered this MOU to establish a framework for state-of-the art research, and to set out potential areas in which both organisations intend to collaborate to identify and capitalise on mutually beneficial opportunities. Macquarie University currently operates Macquarie University Hearing, located at the Australian Hearing Hub and driven to transform hearing health. This is a University initiative leading research in population health, policy, education and practice in hearing, speech, listening and language.

COLLABORATION PARTNERSHIP

#r&d

View Analyst & Ambassador Comments
Go to original news
Aug 17,2022

Security Health Plan Selects Freespira as New Benefit Offering for Many Members with Panic Disorder and Post-Traumatic Stress Disorder

Freespira, Inc., maker of the first FDA-cleared digital therapeutic treatment for panic attacks, panic disorder and post-traumatic stress disorder (PTSD), today announced a partnership with Security Health Plan to make its innovative treatment available to many Security Health Plan members. The organization’s selection of Freespira is yet another illustration of Security Health Plan’s commitment to pioneering advancements in telemedicine and virtual care to improve members’ physical and mental health, as well as manage healthcare costs while providing equitable access to a high-quality healthcare experience for all members, regardless of location or type of insurance coverage.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Sep 07,2022

Orexo’s partner Trinity Health today announces the availability of vorvida® and deprexis® to patients

Orexo AB today announces the Integrated Healthcare System, Trinity Health in North Dakota, in partnership with Orexo, is expanding patient access to digital therapeutics. Trinity Health will now offer Orexo’s evidence-based digital therapies vorvida® and deprexis® to help patients manage depression and excessive drinking. During the last year, Orexo and Trinity Health have collaborated to establish new administrative processes and support systems to ensure effective patient access to these innovative digital therapies and reimbursement of the products through a collaborative care model.

COLLABORATION PARTNERSHIP

#institution

#cbt

#reimbursement

View Analyst & Ambassador Comments
Go to original news
Sep 15,2022

Big Health Digital Therapeutics Daylight and Sleepio Selected for Evernorth Digital Health Formulary

Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced that Daylight for anxiety and Sleepio for insomnia have been added to the Evernorth Digital Health Formulary. By extending access to Daylight and Sleepio to employers and health plans through Evernorth’s Digital Health Formulary, more patients will have access to safe, effective evidence-based solutions for anxiety and insomnia. Daylight and Sleepio can be used alongside medications or as a clinical grade alternative to medications, or when talk therapy is not accessible.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Sep 28,2022

Woebot Health is part of BrightInsight Ecosystem

Woebot Health, the world’s first mental health ally for people and businesses, with products that put personal growth in people’s hands, wherever they are is part of BrightInsight Ecosystem, a network of the world’s leading healthcare and technology companies collaborating to solve healthcare’s biggest challenges to drive digital innovation, adoption and engagement.

COLLABORATION PARTNERSHIP

#institution

#chatbot

View Analyst & Ambassador Comments
Go to original news
Sep 29,2022

Wellbeing Digital to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics

Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate in the Cantor Fitzgerald Mental Health Clinics Symposium to be held virtually on October 11, 2022 at 9:00 a.m. ET.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to MENTAL HEALTH